Cardiol Therapeutics inc (CRDL) Annual Balance Sheets

Annual · GAAP · USD millions
Access CRDL quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Cardiol Therapeutics inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2020)
Assets
Cash And Cash Equivalents15.62
Cash & Short-term Investments15.00
Accounts receivable0.04
Notes Receivable, Current0.00
Other Current Assets1.55
Total Current Assets17.14
Equipment/Property/Plant Net0.09
Intangible Assets0.00
Intangible AssetsAnd Goodwill0.00
Other Current Receivables0.13
Current Prepaid Expenses1.42
Property Plant And Equipment Including Rightofuse Assets-
Total Assets17.23
Liabilities
Accounts Payable2.54
Other Liabilities, Current4.33
Total Current Liabilities4.12
Total Long-term Debt0.00
Other liabilities, Noncurrent0.07
NoncurrentLeaseLiabilities0.07
Total Liabilities4.19
Stockholders' Equity
Other Equity13.69
Common Stockholder's Equity13.69
Total Stockholder's Equity13.04
Liabilities & Stockholder's Equity17.23
4 historic quarters locked

Sign in to unlock the full Cardiol Therapeutics inc balance sheet history.

About Cardiol Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037844

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License